Diagnosing MDS/MPNs currently relies on clinical manifestations, blood and bone marrow changes, no characteristic chromosome changes, and should, except BCR/ABL1, PDGFRα, PDGFRβ, PGFR1 and MLL genes. Here, KMT2A is linked to myelodysplastic syndrome.